Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis

20260 citationsJournal Articlegold Open Access

Authors

Finerenone demonstrated kidney benefits, favorable trends on CV outcome, and a manageable safety profile in the FIDELITY Chinese subpopulation.

Good health and well-being

Published in: Kidney Diseases

Volume 12, Issue 1, pp. 318-329

Field-Weighted Citation Impact: 0.00